(IBDX) iShares Trust - iShares - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3128 • Target Maturity

IBDX: Fixed, Income, Securities, Corporate, Bonds, Target, Maturity

The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is designed to track the performance of investment-grade corporate bonds maturing in 2032. The fund may invest in securities of non-U.S. issuers to align with its underlying index. It allocates at least 80% of its assets to index components and at least 90% to fixed income securities consistent with the index. The ETF is non-diversified, meaning it can concentrate holdings in fewer issuers.

Technically, IBDX shows a sideways trend with support near its 20-day SMA of 24.58 and resistance at its 50-day SMA of 24.65. The 200-day SMA at 24.45 suggests longer-term stability. Average trading volume of 133,400 shares indicates moderate liquidity. The ATR of 0.21 reflects low price volatility. Fundamentally, with AUM of $1.022 billion, the ETF demonstrates investor interest in its target maturity strategy. Expect IBDX to remain range-bound near current levels, with potential upside driven by its alignment to the 20-day SMA and continued demand for corporate bonds with defined maturities.

Additional Sources for IBDX ETF

IBDX ETF Overview

Market Cap in USD 1,048m
Category Target Maturity
TER 0.10%
IPO / Inception 2022-06-28

IBDX ETF Ratings

Growth Rating 39.8
Fundamental -
Dividend Rating 70.0
Rel. Strength -5.15
Analysts -
Fair Price Momentum 24.74 USD
Fair Price DCF -

IBDX Dividends

Dividend Yield 12m 5.08%
Yield on Cost 5y 5.66%
Annual Growth 5y 28.83%
Payout Consistency 100.0%

IBDX Growth Ratios

Growth Correlation 3m 14.1%
Growth Correlation 12m 54.7%
Growth Correlation 5y 85.1%
CAGR 5y 3.98%
CAGR/Max DD 5y 0.32
Sharpe Ratio 12m 0.14
Alpha 1.04
Beta 0.019
Volatility 7.16%
Current Volume 208.3k
Average Volume 20d 121k
What is the price of IBDX stocks?
As of May 22, 2025, the stock is trading at USD 24.59 with a total of 208,306 shares traded.
Over the past week, the price has changed by -0.04%, over one month by +0.91%, over three months by +0.36% and over the past year by +5.37%.
Is iShares Trust - iShares a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares Trust - iShares (NYSE ARCA:IBDX) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.83 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBDX as of May 2025 is 24.74. This means that IBDX is currently overvalued and has a potential downside of 0.61%.
Is IBDX a buy, sell or hold?
iShares Trust - iShares has no consensus analysts rating.
What are the forecast for IBDX stock price target?
According to ValueRays Forecast Model, IBDX iShares Trust - iShares will be worth about 26.7 in May 2026. The stock is currently trading at 24.59. This means that the stock has a potential upside of +8.66%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.7 8.7%